T 3196/19 (Anti-PD-1 antibody/DANA-FARBER GENETICS INSTITUTE) of 15.05.2020
- European Case Law Identifier
- ECLI:EP:BA:2020:T319619.20200515
- Date of decision
- 15 May 2020
- Case number
- T 3196/19
- Petition for review of
- -
- Application number
- 10075561.0
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Assays for screening anti-pd-1 antibodies and uses thereof
- Applicant name
- Dana-Farber Cancer Institute, Inc.
Genetics Institute, LLC - Opponent name
- -
- Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 111(1) (2007)European Patent Convention Art 112a(2)(c) (2007)European Patent Convention Art 113 (2007)European Patent Convention Art 123(2) (2007)European Patent Convention Art 76(1) (2007)European Patent Convention R 106 (2007)European Patent Convention R 137(3) (2010)Rules of procedure of the Boards of Appeal Art 12(4) (2007)Rules of procedure of the Boards of Appeal Art 13(1) (2020)
- Keywords
- Main request and auxiliary requests 1 to 7 - added subject-matter (yes);
Auxiliary requests 8 to 14 - admitted into the appeal proceedings (no);
Appellant's right to be heard - violation (no); - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.